The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants

Pediatrics

Volumn 106, Issue 2 I, 2000, Pages 244-250

  Bromberger, Patricia ^a   Lawrence, Jean M ^b   Braun, David ^c   Saunders, Brian ^a   Contreras, Richard ^b   Petitti, Diana B ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b KAISER PERMANENTE   (United States)

^c WOODLAND HILLS MEDICAL CENTER   (United States)

Author keywords

Clinical signs; Group B streptococcal infection; Intrapartum antibiotics; Maternal risk; Neonatal infections

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; HUMAN; INFANT; INFECTION RISK; LABOR; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

EID: 0033885813     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.106.2.244     Document Type: Article

References (44)

1. Group B streptococcal neonatal and infant infections
2. Transmission of group B streptococci among parturient women and their neonates
3. Group B streptococcal infections
4. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
5. Ampicillin prevents intrapartum transmission of group B streptococcus
6. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci
7. Strategies for chemoprophylaxis of GBS early-onset infections
8. Prevention of early onset of group B streptococcal disease with selective intrapartum chemoprophylaxis
9. Group B streptococcus (GBS) and neonatal infections: The case for intrapartum chemoprophylaxis
10. Prevention of neonatal group B streptococcal disease: Intrapartum detection and chemoprophylaxis of heavily colonized parturients
11. Management of asymptomatic, term gestation neonates born to mothers treated with intrapartum antibiotics
12. Impact of maternal group B streptococcal screening on pediatric management in full-term newborns
13. Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care
14. Prevention of perinatal group B streptococcal disease: A public health perspective
15. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection
16. Prevention of neonatal group B streptococcal sepsis: Is routine antenatal screening appropriate
17. The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease
18. Preventing neonatal group B streptococcal disease: Cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics
19. Sepsis syndrome and septic shock in pediatrics: Current concepts of terminology, pathophysiology, and management
20. Recognition, stabilization and transport of the high risk newborn
21. Tachycardia as a sign of early onset neonatal sepsis
22. Early diagnosis of neonatal sepsis using hematologic scoring system
23. Early onset group B streptococcal disease: Seven year experience and clinical scoring system
24. Prospective studies of group B streptococcal infections in infants
25. Opportunities for prevention of perinatal group B streptococcal disease: A multistate surveillance analysis
26. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis
27. Early-onset group B streptococcal sepsis: A current assessment
28. Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome
29. Study of the usefulness of clinical and hematologic findings in the diagnosis of neonatal bacterial infections
30. The changing spectrum of group B streptococcal disease in infants: An eleven-year experience in a tertiary care hospital
31. Obstetric factors related to bacteremia in the newborn infant
32. Persistent group B streptococcal bacteremia without clinical 'sepsis' in infants
33. Outcome of term gestation neonates whose mothers received intrapartum antibiotics for suspected chorioamnionitis
34. Neonatal group B streptococcal infection in a managed care population
35. Fatal group B streptococcal pneumonia in neonates
36. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease
37. Failure of the urinary group B streptococcal antigen test as a screen for neonatal sepsis
38. Latex agglutination detection of group B streptococcal inoculum in urine
39. Early onset group B streptococcal neonatal infection in Oxford 1985-96
40. Clinical application of urine antigen detection in early onset group B streptococcal disease
41. Diagnostic audit of C reactive protein in neonatal infection
42. Increased levels of tumor neurosis factor-α (TNF-α) and interleukin-Iβ (IL-Iβ) in tracheal aspirates of newborns with pneumonia
43. Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis